9-90867065-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_003177.7(SYK):c.847-66G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.804 in 1,583,454 control chromosomes in the GnomAD database, including 513,383 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.85 ( 54736 hom., cov: 31)
Exomes 𝑓: 0.80 ( 458647 hom. )
Consequence
SYK
NM_003177.7 intron
NM_003177.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.67
Genes affected
SYK (HGNC:11491): (spleen associated tyrosine kinase) This gene encodes a member of the family of non-receptor type Tyr protein kinases. This protein is widely expressed in hematopoietic cells and is involved in coupling activated immunoreceptors to downstream signaling events that mediate diverse cellular responses, including proliferation, differentiation, and phagocytosis. It is thought to be a modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 9-90867065-G-A is Benign according to our data. Variant chr9-90867065-G-A is described in ClinVar as [Benign]. Clinvar id is 2688084.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.933 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYK | NM_003177.7 | c.847-66G>A | intron_variant | ENST00000375754.9 | NP_003168.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYK | ENST00000375754.9 | c.847-66G>A | intron_variant | 1 | NM_003177.7 | ENSP00000364907.4 | ||||
SYK | ENST00000375746.1 | c.847-66G>A | intron_variant | 1 | ENSP00000364898.1 | |||||
SYK | ENST00000375747.5 | c.846+1968G>A | intron_variant | 1 | ENSP00000364899.1 | |||||
SYK | ENST00000375751.8 | c.846+1968G>A | intron_variant | 1 | ENSP00000364904.4 |
Frequencies
GnomAD3 genomes AF: 0.845 AC: 128456AN: 152030Hom.: 54677 Cov.: 31
GnomAD3 genomes
AF:
AC:
128456
AN:
152030
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.799 AC: 1144197AN: 1431306Hom.: 458647 AF XY: 0.800 AC XY: 571313AN XY: 713874
GnomAD4 exome
AF:
AC:
1144197
AN:
1431306
Hom.:
AF XY:
AC XY:
571313
AN XY:
713874
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.845 AC: 128574AN: 152148Hom.: 54736 Cov.: 31 AF XY: 0.849 AC XY: 63129AN XY: 74374
GnomAD4 genome
AF:
AC:
128574
AN:
152148
Hom.:
Cov.:
31
AF XY:
AC XY:
63129
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3194
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 95. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at